These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7467395)
1. The metabolic fate of tizoprolique acid in baboons. Kirkpatrick D; Girkin R; Chasseaud LF; Hawkins DR; Conway B Xenobiotica; 1980 Nov; 10(11):797-803. PubMed ID: 7467395 [TBL] [Abstract][Full Text] [Related]
2. Disposition in rats and dogs of ciglitazone, a new antidiabetic agent. Torii H; Yoshida K; Tsukamoto T; Tanayama S Xenobiotica; 1984 Mar; 14(3):259-68. PubMed ID: 6711015 [TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog. Naitoh T; Mishima M; Kawaguchi S; Matsui K; Andoh T; Kagei K; Kakiki M; Yuzuriha T; Horie T Xenobiotica; 1997 Oct; 27(10):1053-70. PubMed ID: 9364742 [TBL] [Abstract][Full Text] [Related]
4. The metabolic fate of 14C-ximoprofen in rats, baboons and humans. Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835 [TBL] [Abstract][Full Text] [Related]
5. The metabolism of the anti-inflammatory drug eterylate in rat, dog and man. Wood SG; John BA; Chasseaud LF; Johnstone I; Biggs SR; Hawkins DR; Priego JG; Darragh A; Lambe RF Xenobiotica; 1983 Dec; 13(12):731-42. PubMed ID: 6144210 [TBL] [Abstract][Full Text] [Related]
6. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog. Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858 [TBL] [Abstract][Full Text] [Related]
8. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans. Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700 [TBL] [Abstract][Full Text] [Related]
9. The metabolism of salicylidene benzylamine, a pro-drug for salicylate, in rats and dogs. Kirkpatrick D; Hawkins DR; Chasseaud LF; Finn CM; Conway B; Al-Ani MR; Al-Sayyab AF Xenobiotica; 1983 Jan; 13(1):53-64. PubMed ID: 6858201 [TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
11. Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers. Takusagawa S; van Lier JJ; Suzuki K; Nagata M; Meijer J; Krauwinkel W; Schaddelee M; Sekiguchi M; Miyashita A; Iwatsubo T; van Gelderen M; Usui T Drug Metab Dispos; 2012 Apr; 40(4):815-24. PubMed ID: 22269146 [TBL] [Abstract][Full Text] [Related]
12. The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics. Dieterle W; Faigle JW; Imhof P; Sulc M; Wagner J Xenobiotica; 1984 Apr; 14(4):303-10. PubMed ID: 6464500 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans. Renzulli C; Nash M; Wright M; Thomas S; Zamuner S; Pellegatti M; Bettica P; Boyle G Drug Metab Dispos; 2011 Feb; 39(2):215-27. PubMed ID: 21045199 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog. John BA; Chasseaud LF; Wood SG; Forlot P Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426 [TBL] [Abstract][Full Text] [Related]
18. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179 [TBL] [Abstract][Full Text] [Related]
19. The fate of saccharin impurities: the metabolism and excretion of 3-amino [3-14C]benz[d]-isothiazole-1,1-dioxide and 5-chlorosaccharin in the rat. Renwick AG Xenobiotica; 1978 Aug; 8(8):487-94. PubMed ID: 695692 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine. Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]